NOVALGINA Trademark

Trademark Overview

On Monday, August 19, 2024, a trademark application was filed for NOVALGINA with the United States Patent and Trademark Office. The USPTO has given the NOVALGINA trademark a serial number of 98704743. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, March 10, 2025. This trademark is owned by A. Nattermann & Cie. GmbH. The NOVALGINA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of pain and fever
novalgina

General Information

Serial Number98704743
Word MarkNOVALGINA
Filing DateMonday, August 19, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, March 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of pain and fever

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameA. Nattermann & Cie. GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFrankfurt am Main 65929
DE

Trademark Events

Event DateEvent Description
Monday, August 19, 2024NEW APPLICATION ENTERED
Monday, August 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 22, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, August 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 8, 2024LETTER OF PROTEST EVIDENCE FORWARDED
Thursday, February 20, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Thursday, February 20, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 28, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 28, 2025ASSIGNED TO LIE
Monday, March 3, 2025LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Wednesday, March 5, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 10, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 10, 2025SUSPENSION LETTER WRITTEN
Monday, March 10, 2025LETTER OF SUSPENSION E-MAILED
Monday, February 24, 2025ASSIGNED TO EXAMINER

Related Keywords

novalgina fever pain treatment products pharmaceutical